Cascades Capital Asset Management, LLC

Position in ABBV — AbbVie Inc.

CIK 2035512 GREENSBORO, NC

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,431,831

+$198,011 QoQ

Shares Held

5,690

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.00%

of 13F equity value

Holder Rank

#2,223

of 4,153 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cascades Capital Asset Management, LLC holds $6,734,291 across 6 Drug Manufacturers - General names. ABBV ranks #2 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,539	$3,045,353
2	ABBV	AbbVie Inc. This page	5,690	$1,431,831
3	JNJ	Johnson & Johnson	3,461	$878,990
4	AMGN	Amgen Inc	2,146	$777,109
5	MRK	Merck & Co., Inc.	3,016	$387,556
6	NVS	Novartis AG	1,362	$213,452

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,431,831	5,690	+0.3%	Shares	Sole	2026-08-14
2026-03-31	$1,233,820	5,673	-1.5%	Shares	Sole	2026-05-15
2025-12-31	$1,316,102	5,760	+0.3%	Shares	Sole	2026-02-04
2025-09-30	$1,329,965	5,744	+0.3%	Shares	Sole	2025-11-14
2025-06-30	$1,063,045	5,727	+0.4%	Shares	Sole	2025-08-14
2025-03-31	$1,195,730	5,707	-3.9%	Shares	Sole	2025-05-15
2024-12-31	$1,055,004	5,937	-0.4%	Shares	Sole	2025-02-13
2024-09-30	$1,177,573	5,963	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.